Bedrest and sarcopenia

Coker, Robert H.; Wolfe, Robert R.

Current Opinion in Clinical Nutrition & Metabolic Care: January 2012 - Volume 15 - Issue 1 - p 7–11
doi: 10.1097/MCO.0b013e32834da629
AGEING: BIOLOGY AND NUTRITION: Edited by Ronni Chernoff and Tommy Cederholm

Purpose of review: The primary focus of this review is to characterize the physiological elements of sarcopenia. In addition, we will also describe the impact of bedrest on sarcopenia and how various countermeasures may be able to offset the deleterious clinical consequences of unanticipated bedrest or hospitalization. It is well known that the aging process presents many challenges to the maintenance of overall health. With the increasing rate of obesity and the potentially simultaneous development of sarcopenia, bedrest presents a difficult clinical challenge to the elderly individual.

Recent findings: The etiology of accelerated sarcopenia has been described as a syndrome. The characteristics of this syndrome include combined alterations in neuromuscular control and muscle protein synthesis that increase the risk of morbidity and mortality in the elderly population. Moreover, the acute onset of bedrest-induced insulin resistance may further complicate the nutritionally derived maintenance of muscle mass and physical function.

Summary: Even though many questions remain unresolved concerning the optimal clinical management of elderly individuals who undergo unanticipated bedrest, the supplementation of essential amino acids has shown promise as a therapeutic strategy to minimize the detrimental influence of hospitalization in the elderly. In turn, this nutritional adjunctive therapy may reduce the length of stay and the likelihood of repeated hospitalization.

Department of Geriatrics and the Center for Translational Research in Aging and Longevity, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

Correspondence to Robert H. Coker, PhD, Center for Translational Research in Aging and Longevity, Donald W. Reynolds Institute on Aging, 4301W, Markham, Slot 806, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Tel: +1 501 526 5707; fax: +1 501 526 5710; e-mail:

Article Outline
Back to Top | Article Outline


The term ‘sarcopenia’ was first suggested in the late 1980s [1]. Since that time, there has been tremendous increase in scientific investigation into the basic and clinical understanding of this syndrome [2]. Realizing that sarcopenia itself is a complex syndrome composed of nutritional deficiency, chronic inflammation, insulin resistance and a precipitous decline in anabolic hormones, it is not surprising that the acute influence of bedrest may exacerbate the cause of sarcopenia [3].

Back to Top | Article Outline


Sarcopenia is directly related to reductions in mobility and functional status that lead to an increased risk of mortality [4]. Due to the nature of the syndrome, European Working Group for Sarcopenia in Older Persons recently established a clinical definition and diagnostic criteria for the age-related development of sarcopenia [5]. These criteria were based on the consensus between several international societies, including the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics European Region, and the International Association of Nutrition and Aging. Moreover, the syndrome was described in phases such as presarcopenia, sarcopenia and severe sarcopenia, depending on the loss of strength and power that is closely associated with the loss of muscle mass [5]. In addition, absolute strength and/or power have been proposed as a better predictor of decreased functional status that the change in strength itself [6▪]. Along with the assessment of physical function and muscle mass [7], this information should be utilized in the clinical setting to classify muscle function and characterize the risk of subsequent disability.

The consensus of this working group was that the syndrome of sarcopenia should be established from an algorithm [5]. This algorithm would employ three primary components, and include low physical performance (i.e., gait speed), low muscle strength, and low muscle mass. In this way, the complex interplay between different physiological systems could be indirectly assessed and lead to the establishment of cut-off points for the classification of sarcopenia in its progressive stages, according to age and sex [6▪].

Back to Top | Article Outline


It has been demonstrated that leg power in men less that 105 W results in a nine-fold increase in the risk of permanent disability. In women, leg power that falls below 64 W only increases the risk of disability by three-fold. These cut points in muscle strength provide strong evidence of the association between the sarcopenia-induced decrements in muscular strength and how they may ultimately predict permanent disability [7]. They also contribute to the notion that sex differences may exist with respect to the predictive influence of muscular strength on future disability, morbidity and mortality. In fact, studies have shown that age is the strongest predictor of decreased mobility in women, whereas strength remained the primary predictor of decreased mobility in men [7]. This is somewhat counterintuitive realizing that women have lower muscle mass/total mass throughout their adult years. However, studies have also demonstrated a steeper rate of age-related muscular mass and strength in men. This supports this contention that adverse changes in functional status may be more closely related to changes in muscle in men, and functional status may be more affected by osteoarthritis, osteoporosis and depression in women [8].

Back to Top | Article Outline


The rationale behind the establishment of a multifaceted working definition for sarcopenia is based upon the fact that several physiological mechanisms are involved in the cause of the syndrome. These factors include changes in muscle mass, neuromuscular control, and muscle lipid infiltration [5]. In studies comparing the exercise-induced activation of satellite cells that are known to contribute to muscle growth and repair, older mice demonstrated a perturbed sensitivity to the stimulus of exercise that was linked to decreased satellite cell activation and elevations in myostatin [9]. This corroborates with a recent report in humans in whom older individuals were less responsive to the anabolic stimulation of resistance exercise, and this was demonstrated by the reduced activation of mammalian target of rapamycin complex (mTORC)1 signaling and muscle protein synthesis [10].

In addition to the challenges related to anabolic responses to exercise in the elderly, the age-related, progressive loss of motor units may attenuate neuroumuscular transmission [11]. This has been attributed as a contributing factor in the loss of strength and power with age, even though there may only be a 10–15% reduction in the total number of motor units. It has also been suggested that these deleterious, neuromuscular changes may occur in conjunction with the infiltration of lipids into skeletal muscle [11]. Although the initial studies only suggested a relationship between fatty acid infiltration into muscle and a decline in muscle strength [12], recent data suggest strong association between total fat mass and a 7-year decline in muscle mass and strength [13].

It has been previously suggested that increased fat storage (intramuscular, visceral and subcutaneous) may occur in conjunction with changes in plasma adipocytokines such as interleukin-6, tumor necrosis factor-α, and leptin that have a detrimental influence of muscle mass and strength, but recent, long-term studies in older adults did not find any significant changes in plasma adipocytokines over the 7-year period [13]. This is not to say these factors may not be involved but more a detailed analysis of other factors that may also influence the accumulation of intramyocellular lipid (IMCL) may be important. For example, adipose tissue triglyceride lipase (ATGL) catalyzes the first step in muscle triglyceride lipolysis, and ATGL-deficient mice show significant accumulation of IMCL and decreased fatty acid oxidation. We have recently shown that exercise training that results in weight loss increases ATGL mRNA in skeletal muscle [14]. Moreover, other factors that promote the oxidation of fatty acids in skeletal muscle such as carnitine palmitoyl transferase I, adiponection receptor 1, and adiponectin receptor 2 were also increased [14]. These data corroborate with the previous assertion by Lanza and Nair [15], whereby, the age-related sedentary lifestyle tends to foster perturbations in mitochondrial function and insulin resistance. Therefore, metabolic disease, sarcopenia and obesity may work together in a deleterious manner that ultimately results in the development of insulin resistance, decreased functional status, and higher risk of mortality in older individuals [13]. As a result, bedrest or assignment to a nursing home can present an even more challenging clinical situation.

Back to Top | Article Outline


There is overwhelming evidence that bedrest induces the loss of skeletal muscle [16–18]. These detrimental changes in muscle mass due to bedrest have been shown to occur in the vastus lateralis and soleus resulting in decreased maximal torque [18]. In addition, chronically bedridden elderly individuals also lose significant thickness of postural muscles such as rectus abdominis, external oblique, internal oblique, transversus abdominis, thoracic erector spinae, and lumbar mutifidus muscle, leading to an increased risk of falls and disability [17]. Although the prevalence of sarcopenia may vary from 5 to 13% among 60–70 year old individuals, the existence of sarcopenia increases to 68% in the nursing home population. This is most likely due to the combination of increasing age, and more frequent and/or chronic periods of bedrest [19▪]. Ultimately, sarcopenia can result in the development of a debilitating condition termed ‘severe sarcopenia’ that prevents an individual from accomplishing the activities of daily living and initiates a downward spiral in their clinical prognosis [5]. The continuum of sarcopenia has an important significance when it comes to the determination of threshold of muscle mass necessary to maintain physical function, and this seems especially relevant to those who may be confined to a nursing home or who undergo unanticipated bedrest [6▪].

Back to Top | Article Outline


It is also important to mention that essential amino acid (EAA) supplementation has no influence on satiety and, therefore, does not reduce subsequent dietary intake. This is significant because meal replacement may decrease caloric intake due to enhanced satiety [20], potentially leading to malnutrition in the elderly. Although BMI is commonly utilized as an indicator for obesity and a greater risk of mortality, this relationship does not persist in elderly individuals [21]. Without realizing the unique clinical challenges of an elderly individual, it might be confusing. However, this ‘obesity paradox’ is largely on the basis of the notion that increased BMI in the elderly represents an index of protein storage rather than adiposity [22▪], that a BMI below 21 kg/m2 or an acute change in the activity levels of an elderly individual should elicit a modification in nutritional support.

It is quite clear that the most effective strategy to mitigate the impact of bedrest on the development of sarcopenia is adequate nutrition and/or the utilization of resistance exercise [23]. In a recent study in which EAAs were provided with and without the addition of resistance training during bedrest, myostatin levels increased in the group that received EAAs without resistance exercise [24]. From these data, the authors speculated that EAAs provide the least effective countermeasure against muscle loss. Although these results are interesting, it was unclear whether the changes in myostatin transcripts resulted in significant changes in muscle mass or function. In addition, it was not clear whether the formulation of EAAs contained the requisite amount of leucine necessary to provoke the optimal anabolic response in skeletal muscle [25]. It has been shown that the supplementation of EAAs promotes the accretion of lean tissue through increased muscle protein synthesis in older women [26]. Along these lines, recent studies have demonstrated a significant improvement in the insulin-mediated activation of protein kinase B (AKT)/mammalian target of rapamycin (mTOR) in the soleus muscle of aged rats [27], and may be partially responsible for the preservation of muscle function in the elderly when challenged by the deleterious influence of bedrest [28▪▪].

The rationale for the supplementation of EAA may stem from the notion that the recommended daily allowance for protein in the elderly is inadequate. Moreover, this requirement may increase even more when compromising by acute inactivity [28▪▪], and this notion is supported by our data in which elderly individuals without EAA supplementation were found in negative nitrogen balance despite the provision of a diet containing 0.8 g protein per kilogram of body weight [16]. In contrast, supplementation of EAA promoted the preservation of muscle protein synthesis and was closely associated with the preservation of muscle function in these studies, as indicated by maintenance of plantar flexion strength, stair ascent power, stair descent power, and floor transfer time [28▪▪]. The beneficial influence of EAAs may be derived from their simultaneous positive impact on muscle fiber size and motor coordination, and improvements in age-associated alterations in AKT/mTOR signaling have been linked to these positive changes. Other studies in rodents have suggested that amino acids may also protect against protein breakdown and protect against atrophy.

Recently, the positive benefits of EAA supplementation on improving quality of life and muscle strength has even been demonstrated in the institutionalized elderly individuals [29]. In these studies, elderly patients reported a decrease in depressive symptoms and suggested that EAAs may act through direct and indirect pathways. Realizing that improvement of depressive symptoms is of great clinical significance, EAAs may have increased tryptophan levels and this may have been indicative of increased serotonin synthesis. From an indirect standpoint, EAAs improved the Mini Nutritional Assessment Score of these patients, indicating an improvement in nutritional status that would have a beneficial influence on relieving depression. Therefore, supplementation of EAAs may be beneficial in the concomitant improvement of muscle anabolism and amelioration of depressive symptoms, ultimately improving the quality of life in institutionalized elderly patients.

Back to Top | Article Outline


Even though bedrest may be necessary in some clinical scenarios, it has been demonstrated that ambulation and minimizing bedrest are preferred to prevent the deterioration of balance and physical function [30]. Unfortunately, mobilization is not always possible and nutritional supplementation may be logistically challenging in some individuals, other strategies such as low magnitude mechanical signals (LMMS) or vibration countermeasures have been proposed to provide an anabolic stimulus to bone [31] and muscle [32] during bedrest. In a recent study in which middle-aged volunteers were confined to bedrest for 90 days, the utilization of LMMS for 10 min/day promoted significant improvements in ankle, knee and back strength as well as knee endurance [33▪]. These beneficial changes also seemed to attenuate the bedrest-induced deterioration of stability and postural control. Additional studies are necessary that it can be determined whether this type of therapy would be effective in the elderly, and whether the combination of LMMS and EAA supplementation might be even more beneficial in reducing the risk of morbidity and mortality associated with bedrest.

Back to Top | Article Outline


There are many factors responsible for the development of sarcopenia with aging. It seems that the anabolic potential of skeletal muscle may be reduced in the elderly. Insulin resistance, perturbations in muscle metabolism and decreased muscle proliferation may contribute to the difficult clinical condition of sarcopenia. Although bedrest is a common therapy in older adults who are critically ill, deleterious changes in the neuromuscular control and muscle atrophy may become exacerbated by bedrest. Future studies are needed to elucidate whether age-related insulin resistance is a primary factor in facilitating the loss of physical function due to bedrest. We must also further delineate the role or EAA supplementation in the treatment of depression in the elderly. It is clear that the supplementation of EAAs have a beneficial influence on maintaining skeletal muscle mass and muscle function, and may represent an important therapeutic tool in the clinical care of the elderly who undergo unanticipated hospitalization. In addition, LMMS has been shown to also improve muscular strength and preserve postural control. However, many questions still remain regarding how to attenuate the bedrest-induced development of insulin resistance, and other cofactors important to the maintenance of physical function like neuromuscular control and satellite cell proliferation. As these questions are addressed through studies utilizing nutritional supplementation, it may be possible to shed some light on the mitigation of physiological derangements that would otherwise decrease the quality and quantity of life.

Back to Top | Article Outline


The studies were conducted in the General Clinical Research Center at the University of Arkansas for Medical Sciences and the University of Texas Medical Branch at Galveston, and funded by grant MO1 RR14288 (University of Arkansas Medical Sciences), and MO1 RR 00073 (University of Texas Medical Branch) from the National Center for Research Resources. Funding support was also provided by the National Institutes of Health grant PO1 AG023591 (Evans), NIH grant KO1 DK 64716–01(R.H.C.) PO1 AG23591 (R.R.W.), and AHA grant SDA 0335172N (R.H.C.).

Back to Top | Article Outline

Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline


Papers of particular interest, published within the annual period of review, have been highlighted as:

▪ of special interest

▪▪ of outstanding interest

Additional references related to this topic can also be found in the Current World Literature section in this issue (pp. 92–93).

Back to Top | Article Outline


1. Rosenberg I. Summary comments: epidemiological and methodological problems I determining nutritional status of older persons. Am J Clin Nutr 1989; 50:1231–1233.
2. Evans WJ. Skeletal muscle loss: cachexia, sarcopenia and inactivity. Am J Clin Nutr 2010; 91 (suppl.):1123S–1129S.
3. English KL, Paddon-Jones D. Protecting muscle mass and function in older adults during bedrest. Clin Opin Clin Metab Care 2010; 13:34–39.
4. Morley JE, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med 2001; 137:231–243.
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European working group on sarcopenia in older people, sarcopenia – European consensus on definition and diagnosis – report of the European working group on sarcopenia in older people. Age Ageing 2010; 39:412–423.
Vandewoude MF, Cederholm T, Cruz-Jentoft AJ. on behalf of the European Working Group on Sarcopenia in Older People, Relevant outcomes in intervention trials for sarcopenia. J Am Geriatr Soc 2011; 59:1566–1567.

Absolute measurements of strength and power are stronger predictors of decreased functional status than the age-related changes in these variables.

7. Hicks GE, Shardell M, Alley DE, et al. Absolute strength and loss of strength as predictors of mobility decline in older adults: the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2011 [Epub ahead of print].
8. Kim IH. Age and gender differences in relation of chronic diseases to activity of daily living disability for elderly South Koreans: based on representative data. J Prev Med Public Health 2011; 44:32–40.
9. Leiter RS, Peeler J, Anderson JE. Exercise-induced muscle growth is muscle specific and age-dependent. Muscle Nerve 2011; 43:828–893.
10. Fry CS, Drummond MJ, Glynn EL, et al. Aging impairs contraction-induced human skeletal muscle mTORC1 signaling and protein synthesis. Skeletal Muscle 2011; 1:11.
11. Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 2008; 9:213–228.
12. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infilitration as predictors of incident mobility limitations in well functioning older persons. J Gerontol A Biol Sci Med Sci 2006; 60A:324–333.
13. Koster A, Stenholm S, Alley DE, et al. Health ABC StudyBody fat distribution and inflammation among older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010; 18:2354–2361.
14. Yao-Borengasser A, Vijayalakshmi V, Coker RH, et al. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone. Metabolism 2011; 60:1012–1020.
15. Lanza IR, Nair KS. Muscle mitochondrial changes with aging. Am J Clin Nutr 2009; 89 (suppl.):467s–471s.
16. Kortebein P, Ferrando AA, Lombeida J, et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007; 297:1772–1774.
17. Ikezoe T, Mori N, Nakamura M, Ichihashi N. Effects of age and activity due to prolonged bed rest on atrophy of trunk muscles. Eur J Appl Physiol 2011 [Epub ahead of print].
18. Moriggi M, Vasso M, Fania C, et al. Long term bed rest with and without vibration exercise countermeasures: effects on human muscle protein dysregulation. Proteomics 2010; 10:3756–3774.
Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2011 [Epub ahead of print].

Almost 70% of elderly individuals assigned to a nursing home may have sarcopenia.

20. Leidy HJ, Tang M, Armstrong CL, et al. The effects of consuming frequent, higher protein meals on appetite and satiety during weight loss in overweight/obese men. Obesity (Silver Spring) 2011; 19:818–824.
21. Han SS, Kim KW, Kim KL, et al. Lean body mass index: a better predictor of mortality than body mass index in elderly Asians. J Am Geriatr Soc 2010; 58:312–317.
Cereda E, Pedrolli C, Zagami A, et al. Body mass index and mortality in institutionalized elderly. J Am Med Dir Assoc 2011; 12:174–178.

Elderly individuals with a BMI below 21 kg/m2 need nutritional support that includes essential amino acids to prevent the deleterious loss of skeletal muscle.

23. Glover EL, Phillips SM. Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy. Curr Opin Clin Nutr Metab Care 2010; 13:630–634.
24. Brooks NE, Cadena SM, Vannier E, et al. Effects of resistance exercise combined with essential amino acid supplementation and energy deficit on markers of skeletal muscle atrophy and regeneration during bed rest and active recovery. Muscle Nerve 2010; 42:927–935.
25. Deutz NE, Safar A, Schutzler S, et al. Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin Nutr [Epub ahead of print].
26. Sheffield-Moore M, Paddon-Jones D, Gilkison C, et al. Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab 2009; 94:1630–1637.
27. Flati V, Caliaro F, Speca S, et al. Essential amino acids improve insulin activation of ACT/mTOR signaling in soleus muscle of aged rats. Int J Immunopathol Pharmacol 2010; 23:81–89.
Ferrando AA, Paddon-Jones D, Hays NP, et al. EAA supplementation to increase nitrogen intake improves muscle function during bedrest in the elderly. Clin Nutr 2010; 29:18–23.

Supplementation of essential amino acids promoted the preservation of muscle protein synthesis and maintained markers of functional status despite bedrest in elderly individuals.

29. Rondanelli M, Opizzi A, Antoniello N, et al. Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients. Clin Nutr 2011 [Epub ahead of print].
30. Belavy DL, Armbrecht G, Gast U, et al. Countermeasures against lumbar spine deconditioning in prolonged bedrest: resistive exercise with and without whole body vibration. J Appl Physiol 2010; 109:1801–1811.
31. Gilsanz V, Wren TA, Sanchez M, et al. Low-level, high frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res 2010; 21:464–474.
32. Constantino C, Pogliacomi F, Soncini G. Effect of the vibration board on the strength of ankle dorsal and plantar flexor muscles: a preliminary randomized controlled study. Acta Biomed 2006; 77:10–16.
Muir J, Judex S, Qin YX, Rubin C. Postural stability caused by extended bedrest is alleviated by brief daily exposure to low magnitude mechanical signals. Gait Posture 2011; 33:435–529.

Low magnitude mechanical signals provided improvements in ankle, knee and back strength and maintained postural stability despite significant periods of bedrest.


aging; elderly; inactivity; insulin resistance; muscle loss; physical function; protein synthesis

© 2012 Lippincott Williams & Wilkins, Inc.